Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
BMC Ophthalmology|September 26, 2023
Unraveling mucolipidosis type III gamma through whole genome sequencing in late-onset retinitis pigmentosa: a case reportKarl De Geer, Katarzyna Mascianica, Karin Naess, et al.Journal of Inherited Metabolic Disease|August 31, 2023
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patientsMattias Lissing, Axel Wester, Daphne Vassiliou, et al.Inflammation|January 28, 2003
Modulation of plasma levels of soluble adhesion molecules and nitric oxide in healthy volunteers by exposure to swine dustKarl-Gustav Kölbeck, Eliane Sardh, Hans Gyllenhammar, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|December 24, 2009
Combined liver and kidney transplantation in acute intermittent porphyriaStaffan Wahlin, Pauline Harper, Eliane Sardh, et al.Journal of Inherited Metabolic Disease|December 22, 2022
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individualsMattias Lissing, Daphne Vassiliou, Ylva Floderus, et al.Clinical Chemistry|February 25, 2006
Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretionYlva Floderus, Eliane Sardh, Christer Möller, et al.Orphanet Journal of Rare Diseases|October 3, 2024
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension studyEliane Sardh, Manisha Balwani, David C Rees, et al.Journal of Internal Medicine|February 3, 2022
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individualsMattias Lissing, Daphne Vassiliou, Ylva Floderus, et al.Clinical Pharmacology and Therapeutics|September 12, 2021
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the LiverDaphne Vassiliou, Eliane Sardh, Pauline Harper, et al.Plos One|March 14, 2012
Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouseCarmen Unzu, Ana Sampedro, Eliane Sardh, et al.Pageof 3